imatinib mesylate has been researched along with Tumor Lysis Syndrome in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawes, V; Lobo, RH; Sasapu, A; Socola, F | 1 |
| Jordan, K; Kordic, G; Ondecker, J | 1 |
| Buijs, A; Klein, SK; van den Blink, D; van Gijn, M; van Wijnen, M | 1 |
| Bird, R; Henden, A; Keane, C | 1 |
| Al-Kali, A; Farooq, S; Tfayli, A | 1 |
| Haba, Y; Hanzawa, K; Itoyama, S; Kizaki, M; Mori, S; Nemoto, T; Sagawa, M; Saito, Y; Sekiguchi, Y; Tamaru, J; Tokuhira, M; Tomikawa, A; Watanabe, R | 1 |
| Akinci, S; Atalay, HV; Basturk, A; Dilek, I; Hacibekiroglu, T | 1 |
| Bhutani, M; Raina, V; Sharma, A; Vora, A | 1 |
| Akdag, I; Ali, R; Ozan, U; Ozcelik, T; Ozkalemkas, F; Ozkan, A; Ozkocaman, V; Tunali, A | 1 |
| Dann, EJ; Fineman, R; Rowe, JM | 1 |
1 review(s) available for imatinib mesylate and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature.
Topics: Antineoplastic Agents; Biomarkers; Bone Marrow; Eosinophilia; Gene Rearrangement; Humans; Imatinib Mesylate; Leukemia, Myeloid; Protein Kinase Inhibitors; Receptor, Platelet-Derived Growth Factor alpha; Tumor Lysis Syndrome | 2018 |
9 other study(ies) available for imatinib mesylate and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Tumour lysis syndrome: a rare side effect of imatinib therapy for GIST.
Topics: Allopurinol; Diagnosis, Differential; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Protein Kinase Inhibitors; Risk Factors; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase | 2018 |
A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
Topics: Antineoplastic Agents; Base Sequence; Benzamides; Chromosomes, Human, Pair 8; Codon, Nonsense; Core Binding Factor Alpha 2 Subunit; DNA Primers; DNA-Binding Proteins; Female; Humans; Imatinib Mesylate; Karyotyping; Middle Aged; Myeloproliferative Disorders; Piperazines; Pyrimidines; Real-Time Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 1; Transcription Factors; Tumor Lysis Syndrome | 2013 |
Catastrophic tumour lysis syndrome following single dose of imatinib.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms; Piperazines; Pyrimidines; Tumor Lysis Syndrome | 2009 |
Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Lysis Syndrome | 2009 |
[Acute-onset eosinophilic leukemia associated with tumor lysis syndrome after imatinib and steroid pulse therapy].
Topics: Acute Kidney Injury; Aged, 80 and over; Benzamides; Disseminated Intravascular Coagulation; Drug Synergism; Fatal Outcome; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia, Eosinophilic, Acute; Methylprednisolone; Piperazines; Pleural Effusion; Pulse Therapy, Drug; Pyrimidines; Tumor Lysis Syndrome | 2010 |
Is there any protective effect on organs upon higher uric acid level in tumor lysis syndrome?
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Tumor Lysis Syndrome; Uric Acid | 2011 |
Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase.
Topics: Adolescent; Benzamides; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Risk Assessment; Severity of Illness Index; Tumor Lysis Syndrome | 2002 |
Tumour lysis syndrome with acute renal failure during imatinib therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Tumor Lysis Syndrome | 2007 |
Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Male; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tumor Lysis Syndrome | 2002 |